Norges Bank Pulmonx Corp Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Pulmonx Corp stock. As of the latest transaction made, Norges Bank holds 151,200 shares of LUNG stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,200

Holding current value

$1.25 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $872,423 - $1.48 Million	151,200 New	151,200 $958,000
Q4 2023 Feb 09, 2024	BUY	$7.89 - $13.14 $2.97 Million - $4.95 Million	376,900 New	376,900 $4.81 Million
Q3 2023 Nov 13, 2023	SELL	$9.88 - $14.0 $2.23 Million - $3.17 Million	-226,100 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$10.78 - $13.65 $2.44 Million - $3.09 Million	226,100 Added 149.54%	377,300 $4.95 Million
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $2.51 Million - $3.18 Million	-233,100 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$7.49 - $12.54 $1.69 Million - $2.84 Million	226,100 New	226,100 $2.53 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $1.84 Million - $6.49 Million	374,100 New	374,100 $3.15 Million
Q3 2022 Nov 13, 2023	BUY	$15.35 - $23.99 $3.47 Million - $5.42 Million	226,100 New	226,100 $3.77 Million
Q2 2022 Aug 14, 2023	BUY	$14.0 - $27.95 $3.26 Million - $6.52 Million	233,100 New	233,100 $3.43 Million
Q1 2022 May 09, 2022	SELL	$21.13 - $35.65 $863,794 - $1.46 Million	-40,880 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$29.72 - $45.1 $1.21 Million - $1.84 Million	40,880 New	40,880 $1.31 Million
Q3 2021 Nov 14, 2022	BUY	$35.98 - $44.48 $1.47 Million - $1.82 Million	40,880 New	40,880 $1.47 Million
Q3 2021 Nov 05, 2021	SELL	$35.98 - $44.48 $1.04 Million - $1.28 Million	-28,800 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$37.61 - $48.0 $1.08 Million - $1.38 Million	28,800 New	28,800 $1.27 Million

Others Institutions Holding LUNG

# of Institutions

116

Shares Held

30.6M

Call Options Held

400

Put Options Held

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $309M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account